CD79A and infection: Inclusion of apyrase in the vaccine preparation greatly improved the IgA titer induced, similarly to that induced by infection with the live-attenuated apyrase-expressing strain (Figs. 4d, 6d), and generated enhanced protection from challenge with virulent S.Tm (Fig. 6e, f).